Menezes Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 8.50 M
as on 08-12-2024
- Company Age 28 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 15.79 Cr
as on 08-12-2024
- Revenue 113.64%
(FY 2022)
- Profit 77.36%
(FY 2022)
- Ebitda 0.80%
(FY 2022)
- Net Worth 0.79%
(FY 2022)
- Total Assets 1.02%
(FY 2022)
About Menezes Pharmaceuticals
The Corporate was formerly known as Cosme Pharma Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.50 M.
The company has closed loans amounting to ₹15.79 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maryann Menezes, Brenda Menezes, and Christine Menezes serve as directors at the Company.
- CIN/LLPIN
U24232GA1996PLC002040
- Company No.
002040
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 Feb 1996
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Goa
Industry
Company Details
- Location
Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Menezes Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maryann Menezes  | Director | 25-Apr-2006 | Current |
| Brenda Menezes | Director | 30-Oct-2013 | Current |
| Christine Menezes | Director | 30-Oct-2013 | Current |
Financial Performance of Menezes Pharmaceuticals.
Menezes Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 113.64% increase. The company also saw a substantial improvement in profitability, with a 77.36% increase in profit. The company's net worth moved up by a moderate rise of 0.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Menezes Pharmaceuticals?
In 2020, Menezes Pharmaceuticals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cosme Bio-Tech Private LimitedActive 27 years 3 monthsMaryann Menezes, Brenda Menezes and 1 more are mutual person
Cfl Pharmaceuticals LimitedActive 43 years 2 monthsMaryann Menezes, Brenda Menezes and 1 more are mutual person
- Frederick Electro Devices Private LimitedActive 32 years 9 months
Maryann Menezes, Brenda Menezes and 1 more are mutual person
- Menezes Remedies LimitedActive 28 years 10 months
Maryann Menezes, Brenda Menezes and 1 more are mutual person
- Cosme Stocks And Credits Private LimitedActive 28 years 10 months
Maryann Menezes, Brenda Menezes and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 16 Mar 2006 | ₹3.45 Cr | Satisfied |
Bank Of India Creation Date: 16 Mar 2006 | ₹4.17 Cr | Satisfied |
Bank Of India Creation Date: 11 Apr 1998 | ₹4.17 Cr | Satisfied |
How Many Employees Work at Menezes Pharmaceuticals?
Menezes Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Menezes Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Menezes Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
